RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Caroline Appleyard to Receptors, Corticotropin-Releasing Hormone

This is a "connection" page, showing publications Caroline Appleyard has written about Receptors, Corticotropin-Releasing Hormone.
  1. Torres-Rever?n A, Rivera-Lopez LL, Flores I, Appleyard CB. Antagonizing the corticotropin releasing hormone receptor 1 with antalarmin reduces the progression of endometriosis. PLoS One. 2018; 13(11):e0197698.
    View in: PubMed
    Score: 0.649
  2. Pag?n-Busig? JE, L?pez-Carrasquillo J, Appleyard CB, Torres-Rever?n A. Beyond depression and anxiety; a systematic review about the role of corticotropin-releasing hormone antagonists in diseases of the pelvic and abdominal organs. PLoS One. 2022; 17(3):e0264909.
    View in: PubMed
    Score: 0.204
  3. Torres-Rever?n A, Rana M, Gorabi V, Rivera-Lopez LL, Appleyard CB. Short treatment with antalarmin alters adrenal gland receptors in the rat model of endometriosis. PLoS One. 2020; 15(1):e0227456.
    View in: PubMed
    Score: 0.176
  4. Torres-Rever?n A, Rivera LL, Flores I, Appleyard CB. Environmental Manipulations as an Effective Alternative Treatment to Reduce Endometriosis Progression. Reprod Sci. 2018 09; 25(9):1336-1348.
    View in: PubMed
    Score: 0.151
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support